146 related articles for article (PubMed ID: 10524687)
41. Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience.
Yocum DE; Furst DE; Bensen WG; Burch FX; Borton MA; Mengle-Gaw LJ; Schwartz BD; Wisememandle W; Mekki QA;
Rheumatology (Oxford); 2004 Aug; 43(8):992-9. PubMed ID: 15014199
[TBL] [Abstract][Full Text] [Related]
42. Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials.
Doyle MK; Rahman MU; Han C; Han J; Giles J; Bingham CO; Bathon J
Semin Arthritis Rheum; 2009 Oct; 39(2):123-31. PubMed ID: 18823645
[TBL] [Abstract][Full Text] [Related]
43. T cell receptor peptide vaccination in rheumatoid arthritis: a placebo-controlled trial using a combination of Vbeta3, Vbeta14, and Vbeta17 peptides.
Moreland LW; Morgan EE; Adamson TC; Fronek Z; Calabrese LH; Cash JM; Markenson JA; Matsumoto AK; Bathon J; Matteson EL; Uramoto KM; Weyand CM; Koopman WJ; Heck LW; Strand V; Diveley JP; Carlo DJ; Nardo CJ; Richieri SP; Brostoff SW
Arthritis Rheum; 1998 Nov; 41(11):1919-29. PubMed ID: 9811045
[TBL] [Abstract][Full Text] [Related]
44. Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study.
Hetland ML; Stengaard-Pedersen K; Junker P; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen A; Tarp U; Pødenphant J; Hansen G; Lindegaard H; de Carvalho A; Østergaard M; Hørslev-Petersen K;
Arthritis Rheum; 2006 May; 54(5):1401-9. PubMed ID: 16645967
[TBL] [Abstract][Full Text] [Related]
45. Randomized double blind trial of an ayurvedic plant derived formulation for treatment of rheumatoid arthritis.
Chopra A; Lavin P; Patwardhan B; Chitre D
J Rheumatol; 2000 Jun; 27(6):1365-72. PubMed ID: 10852255
[TBL] [Abstract][Full Text] [Related]
46. Effects of clarithromycin in patients with active rheumatoid arthritis.
Ogrendik M
Curr Med Res Opin; 2007 Mar; 23(3):515-22. PubMed ID: 17355733
[TBL] [Abstract][Full Text] [Related]
47. Efficacy and safety of leflunomide 10 mg versus 20 mg once daily in patients with active rheumatoid arthritis: multinational double-blind, randomized trial.
Poór G; Strand V;
Rheumatology (Oxford); 2004 Jun; 43(6):744-9. PubMed ID: 15026583
[TBL] [Abstract][Full Text] [Related]
48. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
49. Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept study.
Bruyn GA; Tate G; Caeiro F; Maldonado-Cocco J; Westhovens R; Tannenbaum H; Bell M; Forre O; Bjorneboe O; Tak PP; Abeywickrama KH; Bernhardt P; van Riel PL;
Ann Rheum Dis; 2008 Aug; 67(8):1090-5. PubMed ID: 18037627
[TBL] [Abstract][Full Text] [Related]
50. A comparison of the efficacy and safety of celecoxib 200 mg and celecoxib 400 mg once daily in treating the signs and symptoms of psoriatic arthritis.
Kivitz AJ; Espinoza LR; Sherrer YR; Liu-Dumaw M; West CR
Semin Arthritis Rheum; 2007 Dec; 37(3):164-73. PubMed ID: 17570469
[TBL] [Abstract][Full Text] [Related]
51. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
[TBL] [Abstract][Full Text] [Related]
52. Efficacy and safety of hydroxychloroquine sulphate in rheumatoid arthritis: a randomized, double-blind, placebo controlled clinical trial--an Indian experience.
Das SK; Pareek A; Mathur DS; Wanchu A; Srivastava R; Agarwal GG; Chauhan RS
Curr Med Res Opin; 2007 Sep; 23(9):2227-34. PubMed ID: 17692155
[TBL] [Abstract][Full Text] [Related]
53. Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study.
Tao X; Younger J; Fan FZ; Wang B; Lipsky PE
Arthritis Rheum; 2002 Jul; 46(7):1735-43. PubMed ID: 12124856
[TBL] [Abstract][Full Text] [Related]
54. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J
Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699
[TBL] [Abstract][Full Text] [Related]
55. Plasmapheresis therapy in rheumatoid arthritis. A controlled, double-blind, crossover trial.
Dwosh IL; Giles AR; Ford PM; Pater JL; Anastassiades TP
N Engl J Med; 1983 May; 308(19):1124-9. PubMed ID: 6339939
[TBL] [Abstract][Full Text] [Related]
56. Treatment of rheumatoid arthritis by immunization with mononuclear white blood cells: results of a preliminary trial.
Smith JB; Fort JG
J Rheumatol; 1996 Feb; 23(2):220-5. PubMed ID: 8882022
[TBL] [Abstract][Full Text] [Related]
57. Immunoglobulin binding properties of the Prosorba immunadsorption column in treatment of rheumatoid arthritis.
Sasso EH; Merrill C; Furst TE
Ther Apher; 2001 Apr; 5(2):84-91. PubMed ID: 11354304
[TBL] [Abstract][Full Text] [Related]
58. Vasculitis secondary to staphylococcal Protein A immunoadsorption (Prosorba column) treatment in rheumatoid arthritis.
Deodhar A; Allen E; Daoud K; Wahba I
Semin Arthritis Rheum; 2002 Aug; 32(1):3-9. PubMed ID: 12219317
[TBL] [Abstract][Full Text] [Related]
59. Prosorba column for rheumatoid arthritis.
Med Lett Drugs Ther; 1999 Jul; 41(1058):69-70. PubMed ID: 10445021
[No Abstract] [Full Text] [Related]
60. Global statistical tests for comparing multiple outcomes in rheumatoid arthritis trials. MIRA Trial Group.
Tilley BC; Pillemer SR; Heyse SP; Li S; Clegg DO; Alarcón GS
Arthritis Rheum; 1999 Sep; 42(9):1879-88. PubMed ID: 10513802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
